February 12, 2018 by Greg Jacobson and Chain Drug Review
Alex Azar, Eli Lilly, Food and Drug Administration, HHS secretary, prescription drug prices, President Donald Trump, Secretary of Health and Human Services, State of the Union, Trump's State of the Union address
2018, Issue 02-12-2018, Issues, Leading Headlines, News, Pharmacy, Retail News

WASHINGTON — In his first State of the Union speech, President Donald Trump renewed his pledge to reduce prescription drug prices, days after a former big pharma executive was sworn in as Secretary of Health and Human Services. Trump had stunned the pharmaceutical industry during his 2016 campaign by declaring that drug manufacturers were “getting
January 25, 2018 by Chain Drug Review
Alex Azar, Chuck Grassley, Eli Lilly, Elizabeth Warren, HHS, HHS secretary, Ron Wyden, Todd Young, Tom Carper, Tom Price, U.S. Department of Health & Human Services
Leading Headlines, Pharmacy, Retail News

WASHINGTON — Former Eli Lilly and Co. executive Alex Azar has been confirmed by the Senate as the new secretary of the U.S. Department of Health & Human Services (HHS). Nominated for the HHS secretary post in November by President Donald Trump, Azar was approved by the Senate on Wednesday in a 55-43 vote, mainly
November 14, 2017 by Chain Drug Review
Alex Azar, ational Community Pharmacists Association, B. Douglas Hoey, Bernie Sanders, Eli Lilly, HHS secretary, Lamar Alexander, Lilly USA, President Donald Trump, secretary of the U.S. Department of Health and Human Services, Tom Price
Featured Articles, Leading Headlines, Pharmacy, Retail News

WASHINGTON — Biopharmaceutical industry executive Alex Azar has been nominated as secretary of the U.S. Department of Health and Human Services (HHS) to fill the post vacated by Tom Price. Azar is currently founder and chairman of Seraphim Strategies LLC, an Indianapolis-based consultancy focused on the biopharma and health insurance industries, including biopharmaceutical sales, marketing, pricing,
February 27, 2017 by Scot Meyer and Chain Drug Review
B. Douglas Hoey, Consumer Healthcare Products Association, HHS secretary, National Association of Chain Drug Stores, National Community Pharmacists Association, Steve Anderson, Tom Price, U.S. Department of Health and Human Services
2017, Issue 02-27-2017, Issues, News
WASHINGTON — Vowing to fix what he called a “broken health care system,” Rep. Tom Price (R., Ga.) was sworn in earlier this month as secretary of the U.S. Department of Health and Human Services. Retail pharmacy groups responded by welcoming Price to his new post as HHS secretary. “We congratulate Rep. Tom Price on
February 6, 2017 by Scot Meyer and Chain Drug Review
Affordable Care Act, Department of Health and Human Services, HHS secretary, Orrin Hatch, Tom Price, Trump administration
2017, Issue 02-06-2017, Issues, News
WASHINGTON — Tom Price, an orthopedic surgeon, a six-term Republican congressman from Georgia and a fierce critic of the Affordable Care Act, faced tough questions from Democrats about ethical issues and policy priorities during his confirmation hearing. But at presstime it appeared that he would be approved as Secretary of the Department of Health and
November 30, 2016 by Chain Drug Review
Affordable Care Act, Centers for Medicare & Medicaid Services, CMS adminstrator, Donald Trump, HHS secretary, NACDS, National Association of Chain Drug Stores, Seema Verma, Steve Anderson, Tom Price, U.S. Department of Health and Human Services
Featured Articles, Leading Headlines, Pharmacy, Retail News

ARLINGTON, Va. — The National Association of Chain Drug Stores said it’s ready to work with President-elect Donald Trump’s nominees to lead the U.S. Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS). Trump on Tuesday named U.S. Rep. Tom Price (R., Ga.) as HHS secretary and Seema